Domaine Carneros Celebrates 20 Years of Solar Leadership This Earth Day
NAPA, Calif., April 16, 2025 (SEND2PRESS NEWSWIRE) — As Earth Day approaches on April 22, Domaine Carneros is raising a glass to a significant milestone: over two decades of pioneering solar energy in the wine industry. What began in 2003 as the world's largest winery solar installation has evolved into a cutting-edge microgrid system that now provides nearly 80% of the winery's energy needs while reducing carbon emissions by 375 metric tons of CO₂ annually, equivalent to powering 50 homes for a year.
'When we installed our first solar array two decades ago, we were at the forefront of renewable energy adoption in the wine industry,' notes CEO Remi Cohen. 'Today, our advanced microgrid technology represents the next generation of energy independence and environmental stewardship. As climate challenges intensify, Domaine Carneros continues its commitment to leading with a light footprint while crafting the highest quality wines.'
REVOLUTIONARY MICROGRID TECHNOLOGY
In partnership with Schneider Electric, named the world's most sustainable company by Time magazine, Domaine Carneros deployed the EcoStruxure™ Microgrid in 2023, doubling the winery's energy generation capacity. The system integrates 614 upgraded solar panels generating 427 kilowatts of clean energy with a 250KVA battery backup and generator. This infrastructure ensures uninterrupted operations during increasingly common power outages due to wildfires and severe weather events, and the system stores excess solar energy generated during the day for use in the evenings or early mornings during peak demand.
The microgrid's intelligent controls leverage AI to optimize energy usage in real time, resulting in significant operational benefits:
The system also powers four electric vehicle charging stations for guests, seamlessly integrating green technology throughout the visitor experience.
AWARD-WINNING ENVIRONMENTAL PRACTICES
Domaine Carneros' comprehensive approach to sustainability has earned numerous prestigious recognitions, including:
The winery maintains multiple environmental certifications, including California Sustainable Winegrowing Alliance, Napa Green Vineyard & Winery, Bay Area Green Business, and Fish Friendly Farming.
BEYOND ENERGY: COMPREHENSIVE SUSTAINABILITY
Domaine Carneros implements sustainability throughout its operations:
'Our commitment to environmental stewardship is fundamentally rooted in our estate vineyards under Allison Wilson's visionary stewardship,' says Remi Cohen, CEO of Domaine Carneros. 'This commitment is further demonstrated through two decades of solar energy innovation powering our winemaking, ensuring our tradition of excellence thrives sustainably for generations to come.'
ABOUT DOMAINE CARNEROS
Founded in 1987, Domaine Carneros reflects the hallmark of its founder, Champagne Taittinger, in creating a vision of terroir-driven sparkling wine and preserving the quality tenets of the methode traditionelle of sparkling wine production. Located entirely within the Carneros AVA, between Napa and Sonoma counties, the six estate vineyards total approximately 400 acres with 150 acres planted to Chardonnay, and 250 acres planted to Pinot Noir. The winery focuses on making ultra-premium Carneros sparkling wines largely estate grown and limited production Pinot Noirs.
Learn more: https://www.domainecarneros.com/.
MEDIA CONTACT:
For additional information, images, and interview requests, please contact Kimberly Noelle Charles, DipWSET of Charles Communications Associates at [email protected] or 415-701-WINE (9463)
NEWS SOURCE: Domaine Carneros
Keywords: Wines and Vineyards, Domaine Carneros Winery, sustainability, earth day, microgrid, solar power, solar energy, green business, NAPA, Calif.
This press release was issued on behalf of the news source (Domaine Carneros) who is solely responsibile for its accuracy, by Send2Press® Newswire. Information is believed accurate but not guaranteed. Story ID: S2P125546 APNF0325A
To view the original version, visit: https://www.send2press.com/wire/domaine-carneros-celebrates-20-years-of-solar-leadership-this-earth-day/
© 2025 Send2Press® Newswire, a press release distribution service, Calif., USA.
RIGHTS GRANTED FOR REPRODUCTION IN WHOLE OR IN PART BY ANY LEGITIMATE MEDIA OUTLET - SUCH AS NEWSPAPER, BROADCAST OR TRADE PERIODICAL. MAY NOT BE USED ON ANY NON-MEDIA WEBSITE PROMOTING PR OR MARKETING SERVICES OR CONTENT DEVELOPMENT.
Disclaimer: This press release content was not created by nor issued by the Associated Press (AP). Content below is unrelated to this news story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Ketjen Introduces New Breakthrough Catalyst Technology that Effectively Mitigates the Effects of Iron Poisoning in FCC Units
Commercial trial demonstrates SaFeGuard's™ effectiveness in processing opportunity crudes HOUSTON, August 20, 2025--(BUSINESS WIRE)--Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing has launched SaFeGuard™, a new catalyst technology designed to address iron (Fe) poisoning in FCC units. In a recent 30-day full commercial trial, SaFeGuard™ demonstrated a 77% improvement in accessibility with a 50% inventory replacement enabling an increase in unit activity, improved bottoms cracking, and ability to process heavy iron-rich feedstocks. Further testing and predictive modeling suggest that a full 100% inventory changeout could yield up to a 130% increase in accessibility delivering additional improvement in performance. SaFeGuard™ delivers a step change in the contaminant Fe and calcium (Ca) tolerance window by minimizing the Eutectic formation, thereby keeping catalyst pores open. This enables higher activity levels and furthers bottoms cracking, ultimately uplifting profit margins. "We've developed a powerful, safe and sustainable solution that addresses iron poisoning and will increase profitability for our customers by allowing for lower-cost feeds and more efficient operations," said Ketjen's Chief Commercial Officer Henri Tausch. "This new technology is the culmination of decades of research aimed at developing industry leading iron and calcium tolerant catalysis and illustrates our commitment to developing innovative solutions that support the evolving needs of our customers." "SaFeGuard™ is a great option for refiners who are taking advantage of opportunity crudes and even bio feeds because it is just as effective in combating additional contaminants including nickel, vanadium, calcium, sodium, and silicon," said David Leach, Vice President and General Manager, FCC at Ketjen. "It can be used to process iron-rich feedstocks including heavy, resid, tight oil and renewable feeds, and it's also great for units facing accessibility limitations because it requires less frequent catalyst replacement." Ketjen's next generation SaFeGuard™ technology is currently available for use by refiners around the globe. Contact us to learn more about how you can unlock the full potential of your FCC unit. About Ketjen Ketjen is a provider of advanced catalyst solutions to leading producers in the petrochemical, refining and specialty chemicals industries. From fluidized catalytic cracking to clean fuels solutions to hydro-processing to organometallics and curatives, Ketjen delivers safe and reliable solutions that increase production performance and business value. A wholly owned subsidiary of Albemarle Corporation (NYSE: ALB), Ketjen Corporation is headquartered in Houston, Texas, and serves global customers through operations in 25 markets. For more information, visit View source version on Contacts Media Contact: Jennifer Albert, MediaRelations@ Sign in to access your portfolio
Business Wire
4 hours ago
- Business Wire
Ketjen Introduces New Breakthrough Catalyst Technology that Effectively Mitigates the Effects of Iron Poisoning in FCC Units
HOUSTON--(BUSINESS WIRE)--Ketjen Corporation, a leader in catalyst and specialty chemicals manufacturing has launched SaFeGuard™, a new catalyst technology designed to address iron (Fe) poisoning in FCC units. In a recent 30-day full commercial trial, SaFeGuard™ demonstrated a 77% improvement in accessibility with a 50% inventory replacement enabling an increase in unit activity, improved bottoms cracking, and ability to process heavy iron-rich feedstocks. Further testing and predictive modeling suggest that a full 100% inventory changeout could yield up to a 130% increase in accessibility delivering additional improvement in performance. SaFeGuard™ delivers a step change in the contaminant Fe and calcium (Ca) tolerance window by minimizing the Eutectic formation, thereby keeping catalyst pores open. This enables higher activity levels and furthers bottoms cracking, ultimately uplifting profit margins. 'We've developed a powerful, safe and sustainable solution that addresses iron poisoning and will increase profitability for our customers by allowing for lower-cost feeds and more efficient operations,' said Ketjen's Chief Commercial Officer Henri Tausch. 'This new technology is the culmination of decades of research aimed at developing industry leading iron and calcium tolerant catalysis and illustrates our commitment to developing innovative solutions that support the evolving needs of our customers.' 'SaFeGuard™ is a great option for refiners who are taking advantage of opportunity crudes and even bio feeds because it is just as effective in combating additional contaminants including nickel, vanadium, calcium, sodium, and silicon,' said David Leach, Vice President and General Manager, FCC at Ketjen. 'It can be used to process iron-rich feedstocks including heavy, resid, tight oil and renewable feeds, and it's also great for units facing accessibility limitations because it requires less frequent catalyst replacement.' Ketjen's next generation SaFeGuard™ technology is currently available for use by refiners around the globe. Contact us to learn more about how you can unlock the full potential of your FCC unit. About Ketjen Ketjen is a provider of advanced catalyst solutions to leading producers in the petrochemical, refining and specialty chemicals industries. From fluidized catalytic cracking to clean fuels solutions to hydro-processing to organometallics and curatives, Ketjen delivers safe and reliable solutions that increase production performance and business value. A wholly owned subsidiary of Albemarle Corporation (NYSE: ALB), Ketjen Corporation is headquartered in Houston, Texas, and serves global customers through operations in 25 markets. For more information, visit
Associated Press
4 hours ago
- Associated Press
AcCELLerated Biologics to Distribute RegenaLase™ Laser System from IPG Medical Corporation Across the United States
Jupiter, FL August 20, 2025 --( )-- AcCELLerated Biologics, LLC, a leading distributor of regenerative medicine technologies, today announced an exclusive agreement with IPG Medical Corporation, a wholly owned subsidiary of IPG Photonics Corporation, to distribute the RegenaLase™ Laser System throughout the United States. This new dual-wavelength laser platform is engineered to treat musculoskeletal soft tissue, including meniscus cartilage and inflammation. The RegenaLase system features two advanced laser modalities: 1550 nm erbium fiber laser for minimally invasive cartilage surgery 980 nm diode laser for non-invasive photobiomodulation therapy This dual functionality enables physicians to provide both in-office pain relief and advanced cartilage treatment — all from a single, compact, and versatile device. 'This partnership with IPG Medical marks a major milestone in regenerative medicine,' said Steve Whyte, CEO and Founder of AcCELLerated Biologics. The 'RegenaLase system merges laser innovation with non-invasive phototherapy, giving physicians powerful tools to reduce pain and restore cartilage—without the complications of traditional surgery. At AcCELLerated Biologics, we remain committed to being first to market with cutting-edge solutions that empower our physicians to deliver exceptional care to their patients.' 'I recently attended a cadaver training course at RMTI in Jupiter, Florida, to learn in detail how the RegenaLase Laser can treat musculoskeletal pathologies. This laser technology is poised to be a game changer,' said Joshua G. Hackel, MD, FAAFP, RMSK, CAQSM, Sports Medicine Specialist at the Andrews Institute for Orthopaedics and Sports Medicine. 'We are looking forward to conducting a prospective study utilizing the RegenaLase Laser System to treat knee osteoarthritis at the Andrews Research and Education Foundation in Gulf Breeze, Florida.' 'I have been fortunate in my career to be involved in some groundbreaking technology and techniques. It has allowed me to help many patients heal from their injuries,' said Michael A. Scarpone, D.O. Scarpone Sports Regenerative, Steubenville, Ohio. 'The RegenaLase laser is one of those technologies that has the potential to help a great many patients with knee osteoarthritis and beyond. I am excited to be participating in this project — past, present, and future.' Clinical studies have demonstrated the effectiveness of RegenaLase when paired with optional biologic adjuncts such as Platelet-Rich Plasma (PRP), adipose tissue, and bone marrow aspirate. Patients have shown significant reductions in pain and measurable improvements in joint function. Designed with ergonomics and flexibility in mind, the system is well-suited for both surgical suites and office-based settings, enabling highly personalized treatment protocols, based on delivering multiple, separated microscopic columns of coagulation to the target tissue. 'We're excited to partner with AcCELLerated Biologics to expand access to the RegenaLase system across the United States,' said Alexander Vybornov, IPG Medical Sr. Director of Partnerships & Commercialization. 'With our expertise in laser innovation and AcCELLerated Biologics' strong clinical support and distribution network, more physicians will be empowered to adopt this advanced laser therapy for pain management and advanced musculoskeletal tissue treatment.' The RegenaLase system is FDA-cleared for coagulation of soft tissue including meniscus cartilage, and temporary relief of pain via tissue heating. About AcCELLerated Biologics, LLC AcCELLerated Biologics is a premier distributor of regenerative medicine devices and biologics, dedicated to equipping physicians with the most advanced technologies to improve patient outcomes. Learn More: Media Contact: Sharon Bruneau [email protected] Contact Information: AcCELLerated Biologics Sharon Bruneau +1 (407) 230-3290 Contact via Email Read the full story here: AcCELLerated Biologics to Distribute RegenaLase™ Laser System from IPG Medical Corporation Across the United States Press Release Distributed by
